Derivative Instruments |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Derivative Instruments | |
| Derivative Instruments | 7. Derivative Instruments
From time-to-time Solitario has sold covered call options against its prior holdings of shares of common stock of Kinross Gold Corp. (“Kinross”) included in marketable equity securities. The business purpose of selling covered calls was to provide additional income on a limited portion of shares of Kinross that Solitario may sell in the near term, which is generally defined as less than one year and any changes in the fair value of its covered calls are recognized in the statement of operations in the period of the change. In August 2024, Solitario sold covered calls against its holdings of Kinross for net proceeds of $39,000. Solitario recorded an unrealized loss on derivative instruments of $206,000 during the three months ended March 31, 2025 related to its Kinross calls. Solitario settled its Kinross calls in May 2025, upon the sale of its holdings of Kinross. Solitario has no derivative instruments outstanding at March 31, 2026 and December 31, 2025. |
| X | ||||||||||
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|